Phase 2 Study of a Live Attenuated Measles Virus-Vectored Chikungunya Vaccine in a Previously Epidemic Area
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2018
At a glance
- Drugs Chikungunya virus vaccine (Primary) ; Measles mumps and rubella virus vaccine
- Indications Chikungunya virus infections
- Focus Adverse reactions
- Sponsors Themis Bioscience
- 19 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Aug 2017 Status changed from not yet recruiting to recruiting.
- 01 Aug 2017 Planned initiation date changed from 24 May 2017 to 1 Aug 2017.